Next Article in Journal
Novel, First-in-Human, Oral PCLX-001 Treatment in a Patient with Relapsed Diffuse Large B-Cell Lymphoma
Previous Article in Journal
Is It Time to Commit to a Process to Re-Evaluate Oncology Drugs? A Descriptive Analysis of Systemic Therapies for Solid Tumour Indications Reviewed in Canada from 2017 to 2021
 
 
Article

Article Versions Notes

Curr. Oncol. 2022, 29(3), 1932-1938; https://doi.org/10.3390/curroncol29030157
Action Date Notes Link
article xml file uploaded 13 March 2022 09:00 CET Original file -
article xml uploaded. 13 March 2022 09:00 CET Update https://www.mdpi.com/1718-7729/29/3/157/xml
article pdf uploaded. 13 March 2022 09:00 CET Version of Record https://www.mdpi.com/1718-7729/29/3/157/pdf
article html file updated 13 March 2022 09:02 CET Original file -
article html file updated 1 August 2022 05:27 CEST Update https://www.mdpi.com/1718-7729/29/3/157/html
Back to TopTop